News of Note—Olympus to study safety, efficacy of upgraded power morcellator

News of note

> Olympus America will conduct a study of 140 hysterectomy patients in an effort to show that its “revamped” power morcellator—which features a bag to keep undetected cancer cells from spreading—is safe and effective. Philadelphia Inquirer story

> CytoSorbents picked up a grant worth more than $700,000 from the U.S. Army Medical Research and Materiel Command to develop new blood-purification treatments to stabilize patients with severe burn injury. Release

Suggested Articles

Janssen is planning its first completely virtual clinical trial, using personal smartphones and wearable devices with no in-person site visits.

Sensyne Health aims to bring its AI tools to America, and it’s enlisting IT giant Cognizant and data infrastructure specialist Agorai to help.

Daré Bioscience added a microchip-based implant to its pipeline and reported data from a pre-pivotal study of a hormone-free contraceptive ring.